Washington State
House of Representatives
Office of Program Research
BILL
ANALYSIS
Health Care & Wellness Committee
HB 1979
Brief Description: Reducing the cost of inhalers and epinephrine autoinjectors.
Sponsors: Representatives Paul, Leavitt, Duerr, Reed, Ormsby, Callan, Kloba, Doglio, Fosse, Ortiz-Self, Hackney and Shavers.
Brief Summary of Bill
  • Requires health plans, including health plans offered to public and school employees, to cap the total out of pocket cost for a 30-day supply of asthma inhalers and a two pack of epinephrine autoinjectors at $35.
Hearing Date: 1/10/24
Staff: Kim Weidenaar (786-7120).
Background:

Cost sharing.
A health plan's cost sharing, the enrollee's share of the costs that they must pay out of pocket through a deductible, coinsurance, or copayment, is typically set by the health plan and often organized into tiers.  State and federal law require some health services to be provided without cost sharing and state law currently caps the total amount that an enrollee is required to pay for a 30-day supply of insulin at $35.

 

Federal law requires high deductible health plans (HDHPs) that have an associated health savings account (HSA) to meet a number of requirements to allow enrollees to maintain tax-exempt contributions and withdrawals for their HSA, including generally prohibiting HDHPs from providing benefits until the minimum deductible for the plan year is satisfied.  Federal law provides an exception to this prohibition for certain preventive care services, which the federal Internal Revenue Service (IRS) guidance has expanded to include specified prescription medications for certain conditions, such as insulin for the treatment of diabetes and inhaled corticosteroids for the treatment of asthma.

 

Asthma Inhalers and Epinephrine Autoinjectors.
Inhalers are small, handheld devices that allow you to breathe medicine in through your mouth, directly to your lungs.  They are often used to treat asthma, but providers may prescribe them for other conditions.  Bronchodilators and corticosteroids are common inhaled medications. 

 

Epinephrine auto-injectors are devices that contain epinephrine, which is used to treat severe allergic reactions called anaphylaxis.  Epinephrine autoinjectors are generally sold in a two pack, in case of user error, product failure, or a second epinephrine autoinjector is necessary. 

Summary of Bill:

Health plans, including health plans offered to public and school employees, issued or renewed on or after January 1, 2025, must cap the total amount that an enrollee is required to pay:

  • for a 30-day supply of covered asthma inhalers at $35; and
  • for a two pack of covered epinephrine autoinjectors at $35, for up to six autoinjectors per plan year. 

 

Prescription asthma inhalers and epinephrine autoinjectors must be covered without being subject to a deductible, and any cost sharing paid by an enrollee must be applied toward the enrollee's deductible obligation, except as provided below for HDHPs with an HSA.

 

For HDHPs offered as a qualifying health plan for an HSA, the health carrier must establish the plan's cost sharing for asthma inhalers that are not on the federal Internal Revenue Service's list of preventive care services and epinephrine autoinjectors at the minimum level necessary to preserve the enrollee's ability to claim tax-exempt contributions and withdrawals from the enrollee's HSA.  If the IRS removes asthma inhalers from the list of preventive care services, the health carrier must establish the plan's cost sharing for the coverage of prescription asthma inhalers at the minimum level necessary to preserve the enrollee's ability to claim tax-exempt contributions from the enrollee's HSA.  If the IRS adds epinephrine autoinjectors to the list of preventive care services, coverage must be provided without being subject to the deductible. 

Appropriation: None.
Fiscal Note: Requested on January 2, 2024.
Effective Date: The bill takes effect 90 days after adjournment of the session in which the bill is passed.